Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2008; 51:2329-2335, doi:10.1016/j.jacc.2007.11.085
© 2008 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nishii, M.
Right arrow Articles by Izumi, T.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Nishii, M.
Right arrow Articles by Izumi, T.
Related Collections
Right arrowRelated Articles

Prognostic Utility of B-Type Natriuretic Peptide Assessment in Stable Low-Risk Outpatients With Nonischemic Cardiomyopathy After Decompensated Heart Failure

Mototsugu Nishii, PhD, MD*, Takayuki Inomata, PhD, MD, Hitoshi Takehana, PhD, MD, Takashi Naruke, MD, Tomoyoshi Yanagisawa, MD, Masahiko Moriguchi, PhD, MD, Sadao Takeda, PhD, MD and Tohru Izumi, PhD, MD

Department of Cardio-angiology, Kitasato University School of Medicine, Sagamihara, Japan.


Figure 1
View larger version (27K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1 ROC Curve for Cutoff Values of BNP Levels at 6 Months Post-Discharge

A B-type natriuretic peptide (BNP) level of 190 pg/ml had the best compromise between sensitivity (96%) and specificity (76%) for predicting readmission for decompensated heart failure or sudden death. ROC = receiver-operating characteristic. Area under curve = 0.91.

 

Figure 2
View larger version (32K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 2 Kaplan-Meier Analyses

Kaplan-Meier curves showing the incidence rate of readmission for decompensated heart failure or sudden death (A) or of readmission alone (B) according to 6-month post-discharge B-type natriuretic peptide (BNP) ranges. B-type natriuretic peptide ranges were <190 (the best cutoff level for predicting readmission or sudden death), 190 to 380, and >380 (its 2-fold level) pg/ml. p < 0.0001 (the log-rank test) versus a BNP range of <190 pg/ml.

 

Figure 3
View larger version (13K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 3 Changes in BNP Levels and Echocardiographic Findings During a Clinically Compensated Status

Changes in B-type natriuretic peptide (BNP) at 3-month intervals after hospital discharge (A) and in echocardiographic variables between discharge and 6 months (B). Solid or open circles indicate BNP levels, echocardiographic dimensions (left ventricular end-diastolic dimension [LVDd]; left atrial diastolic dimension [LADd]), and left ventricular ejection fraction (LVEF) in event-free patients or patients readmitted for decompensated heart failure, respectively. Values are mean ± standard error of the mean. p values comparing changes in BNP and echocardiographic variables between readmitted patients and event-free patients are for repeated measures multivariate analysis of variance over 6 months.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement